Spectra Optia for automatic red blood cell exchange in people with sickle cell disease

6 About this resource

This resource accompanies NICE medical technologies guidance on Spectra Optia for automatic red blood cell exchange in people with sickle cell disease. It is an implementation tool and discusses and summarises the experiences reported by NHS sites which have adopted this technology and shares the learning that took place.

It is the responsibility of local commissioners and providers to implement the guidance at a local level, being mindful of their duty to advance equality of opportunity and foster good relations. Nothing in this document should be interpreted in a way that would be inconsistent with this.